Becton Dickinson & Co. stock falls 2.82% for seventh straight session

9 articles · Updated · MarketWatch · Apr 29

Shares closed at $145.31 on Wednesday, down 22.44% from their 52-week high of $187.35 set in February.
The decline outpaced major indices and most competitors, with trading volume reaching 2.9 million, above the 50-day average.
This extended Becton Dickinson's losing streak amid a broadly weak market, as peers Danaher, Medtronic, and DexCom also posted losses.

What is competitor Danaher's secret to success while Becton Dickinson falters in the same market?

Is Becton Dickinson a 'fallen angel' bargain or a value trap after its 22% plunge?

Why is Becton Dickinson's $2B buyback plan failing to stop its stock's seven-day slide?

With over 9,600 lawsuits pending, what is the hidden financial risk for Becton Dickinson investors?

Will the company's 54-year streak of dividend increases survive its current financial and operational headwinds?